To increase the CML cell targeting of nanoparticles, transferrin was labeled on the surface of PLGA NPs, on account of a higher expression level in CML cells compared with normal cells [48]. Here, TF is linked to chronic myelogenous leukemia, BCR-ABL1 positive.